Literature DB >> 1639470

Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice.

L Yang1, Y Ma, R Schoenfeld, M Griffiths, E Eichwald, B Araneo, J J Weis.   

Abstract

Borrelia burgdorferi produces a mitogen for murine B lymphocytes which can be measured in vitro by polyclonal stimulation of proliferation and immunoglobulin production (R. Schoenfeld, B. Araneo, Y. Ma, L. Yang, and J. J. Weis, Infect. Immun. 60:455-464, 1992). Sonicated B. burgdorferi cells also stimulated IL-6 production by splenocyte cultures. We have used the murine model for Lyme disease described by Barthold et al. (S. W. Barthold, D. S. Beck, G. M. Hansen, G. A. Terwilliger, and K. D. Moody, J. Infect. Dis. 162:133-138, 1990) to determine whether the B. burgdorferi B-cell mitogen is expressed during active infection. To correlate arthritic changes with immune events, we have studied two strains of mice injected with B. burgdorferi; one of them, C3H/HeJ, developed severe disease, and the other, BALB/c, developed only mild disease. C3H/HeJ mice displayed a persistent 10-fold increase in circulating immunoglobulin G (IgG) levels, a 2-fold increase in IgM levels, and a 15-fold increase in peripheral lymph node B-cell numbers, providing evidence of mitogenic activity. Infected BALB/c mice also had evidence for mitogen activity, since the IgG level in serum increased three- to fourfold. The bulk of the increase in circulating IgG levels was not directed against B. burgdorferi antigens, supporting the occurrence of polyclonal B-cell activation. Analysis of IgG isotypes pointed out a contrast between C3H/HeJ and BALB/c mice in that levels of all isotypes were elevated somewhat in both strains of infected mice but IgG2a levels were much more dramatically increased in the C3H/HeJ mice (28-fold) than in the BALB/c mice (4-fold). In this study, interleukin-6 levels were found to be persistently elevated in the serum of infected C3H/HeJ mice. Interestingly, interleukin-6 levels in serum were much lower in the infected BALB/c mice. These findings indicate that the B. burgdorferi mitogen is active in infected animals and may contribute to the inflammatory and immune response to infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639470      PMCID: PMC257278          DOI: 10.1128/iai.60.8.3033-3041.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes.

Authors:  T Tawara; M Shingu; M Nobunaga; T Naono
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.

Authors:  S W Barthold; D H Persing; A L Armstrong; R A Peeples
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

3.  Characterization of Borrelia burgdorferi invasion of cultured endothelial cells.

Authors:  L E Comstock; D D Thomas
Journal:  Microb Pathog       Date:  1991-02       Impact factor: 3.738

4.  Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice.

Authors:  S W Barthold
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

Review 5.  Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens.

Authors:  J A Ledbetter; L A Herzenberg
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

6.  Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6.

Authors:  G S Habicht; L I Katona; J L Benach
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

7.  Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease.

Authors:  D C Zoschke; A A Skemp; D L Defosse
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

8.  Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi.

Authors:  R Schoenfeld; B Araneo; Y Ma; L M Yang; J J Weis
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

9.  Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis.

Authors:  U E Schaible; M D Kramer; R Wallich; T Tran; M M Simon
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

10.  Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis.

Authors:  H Yssel; M C Shanafelt; C Soderberg; P V Schneider; J Anzola; G Peltz
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

View more
  39 in total

Review 1.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease.

Authors:  Xiaohui Wang; Ying Ma; John H Weis; James F Zachary; Carsten J Kirschning; Janis J Weis
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Lipopeptides of Borrelia burgdorferi outer surface proteins induce Th1 phenotype development in alphabeta T-cell receptor transgenic mice.

Authors:  C Infante-Duarte; T Kamradt
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  MyD88- and TRIF-independent induction of type I interferon drives naive B cell accumulation but not loss of lymph node architecture in Lyme disease.

Authors:  Christine J Hastey; Jennine Ochoa; Kimberley J Olsen; Stephen W Barthold; Nicole Baumgarth
Journal:  Infect Immun       Date:  2014-01-22       Impact factor: 3.441

5.  Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection.

Authors:  Pauline Soulas; Anne Woods; Benoit Jaulhac; Anne-Marie Knapp; Jean-Louis Pasquali; Thierry Martin; Anne-Sophie Korganow
Journal:  J Clin Invest       Date:  2005-07-21       Impact factor: 14.808

6.  Fetal outcome in murine Lyme disease.

Authors:  R M Silver; L Yang; R A Daynes; D W Branch; C M Salafia; J J Weis
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters.

Authors:  L C Lim; D M England; N J Glowacki; B K DuChateau; R F Schell
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

8.  Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.

Authors:  K F Tai; Y Ma; J J Weis
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

9.  Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues.

Authors:  L Yang; J H Weis; E Eichwald; C P Kolbert; D H Persing; J J Weis
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Authors:  K P Seiler; Z Vavrin; E Eichwald; J B Hibbs; J J Weis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.